Patients See the Value of Treatment Advertising: Swoop survey

Audio By Carbonatix

NEW YORK--(BUSINESS WIRE)--Sep 8, 2025--

Swoop, a leader in AI-driven, data-powered, and privacy-compliant omnichannel healthcare marketing, today announced the results of a survey revealing the positive impact of pharmaceutical advertising on patients living with chronic conditions. These findings will be unveiled at Fierce Pharma Week 2025 in Philadelphia, during the panel discussion "From Awareness to Action: How Pharma Advertising Impacts the Chronic Condition Journey."

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908433085/en/

Survey highlighting the effectiveness of pharma ads in educating patients and driving meaningful actions finds 53% of respondents took an action related to treatment.

A Swoop survey of 902 MyHealthTeam community members with chronic conditions, conducted between March and July 2025, reveals that treatment advertising influences patients and inspires them to take action.

Key findings from the survey include:

• 97% have seen treatment ads across one or more channels.
• 83% of respondents feel treatment advertising has been beneficial.
• 67% have taken some form of action as a result of seeing treatment ads.
• 53% took action specifically around treatment.

“Treatment ads are influencing patient perceptions and driving meaningful actions in their healthcare journey," said Eric Peacock, Co-founder and President of MyHealthTeam and Swoop Chief Patient Officer. “When patients know what’s coming around the next corner of a chronic condition journey, they can prepare themselves, better understand their treatment options, and have more informed conversations with doctors.”

With pharmaceutical advertisers investing $2.18 billion in television advertising in the first half of 2025, and digital ad spending in healthcare and pharma projected to reach $24.71 billion by 2026, the industry is prioritizing multi-channel patient outreach. The Swoop survey validates the impact of these investments.

Swoop at Fierce Pharma Week

During Fierce Pharma Week, Swoop will share these survey results with the most influential minds in life sciences. The complete survey findings and actionable strategies for consumer and HCP campaigns will be shared during the panel “From Awareness to Action: How Pharma Advertising Impacts the Chronic Condition Journey," Wednesday, September 10, at 9:45 a.m. in Room 121C. This panel features leaders from Novo Nordisk, Swoop, Wavemaker, and a patient advocate.

Attendees can get a full copy of the report, connect with Swoop experts, and explore innovative solutions in pharma marketing at Swoop Booth #1009 every day at the conference.

A dedication to putting the patient first

Pharmaceutical advertising goes beyond simply raising awareness, fueling tangible action and improving conversations with providers. This survey underscores the power of treatment ads to influence patient behavior and improve health outcomes. Swoop’s privacy-safe marketing ecosystem connects patients, healthcare providers, and brands to drive better health outcomes.

Transforming omnichannel marketing by putting patients first, Swoop integrates privacy-safe, data-driven strategies across the healthcare marketing ecosystem, ensuring brands can reach the right audiences at scale. Swoop solutions help brand managers improve patient outcomes through smarter, data-driven intelligence.

Swoop

Swoop is a market leader in privacy-safe, award-winning omnichannel healthcare marketing. Our platform connects patients, HCPs, and brands at scale across all channels, delivering unmatched engagement and proximity to patients throughout their health journey. By combining AI-driven technology with real-world data (RWD), first- and zero-party data, and engagement data, Swoop empowers pharma marketers to make faster, more precise decisions that improve patient outcomes.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250908433085/en/

CONTACT: Marcella Milliet Sciorra

Swoop Chief Marketing Officer

[email protected]

KEYWORD: NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SOFTWARE OTHER HEALTH GENERAL HEALTH INTERNET DATA MANAGEMENT TECHNOLOGY ARTIFICIAL INTELLIGENCE HEALTH TECHNOLOGY MARKETING ADVERTISING COMMUNICATIONS OTHER TECHNOLOGY HEALTH

SOURCE: Swoop

Copyright Business Wire 2025.

PUB: 09/08/2025 09:00 AM/DISC: 09/08/2025 08:59 AM

http://www.businesswire.com/news/home/20250908433085/en